News

December 22, 2014December 22, 2014

Airline Pilots Are Exposed To High Levels of UV-A Cockpit Radiation

News

A group of researchers from the University of California published a recent research letter in JAMA Dermatology whereby they state airline pilots could be exposed to the same levels of ... Read more

December 19, 2014December 19, 2014

Scientists Can Reprogram Skin Fibroblasts Into Melanocytes

News

A new study established a way to convert fibroblasts into functional melanocytes, the body’s pigment-producing cells. The study entitled “Direct conversion of mouse and human fibroblasts to functional melanocytes by ... Read more

December 18, 2014December 18, 2014

New Drugs To Treat Drug Resistant Melanoma Discovered by Researchers

News

In a recent study published in the journal Cancer Cell scientists at The Institute of Cancer Research, London, and the Cancer Research UK Manchester Institute, found a new family of drugs, ... Read more

December 17, 2014December 17, 2014

Study Finds Hair Shaft miRNA-221 Levels Can Be Used As Malignant Melanoma Biomarker

News

In a recent study titled “Hair shaft miRNA-221 levels as a new tumor marker of malignant melanoma”, published in The Journal of Dermatology, a team of researchers from Kumamoto University, Japan, ... Read more

December 16, 2014December 16, 2014

Study Evaluates Number of Nevi Biopsies in U.S. Children

News

In a recent research letter titled “Biopsies of Nevi in Children and Adolescents in the United States, 2009 Through 2013”, published in Jama Dermatology, a group of scientists led by ... Read more

December 15, 2014December 15, 2014

Study Finds Firefighters Have Increased Risk of Melanoma

News

A study led by Monash University researchers found that firefighters have an increased risk of developing melanoma and prostate cancer when compared to the general public. The analysis, appointed by ... Read more

December 12, 2014December 12, 2014

ImmunID To Begin PREDICT-ID Clinical Trial in Metastatic Melanoma Patients

News

A new study called PREDICT-ID Melanoma is going to assess the predictive value of immune profiles for response to the drug agent ipilimumab. The company that developed this agent, ImmunID, ... Read more

December 11, 2014December 11, 2014

Study Finds IL-17 and IL-22 Influence Non-Melanoma Skin Cancer Growth

News

In a recent study titled “Interleukin-17 and Interleukin-22 promote tumor progression in human non-melanoma skin cancer”, published ahead of print in the European Journal of Immunology, a group of researchers from ... Read more

December 10, 2014December 10, 2014

Amgen Begins Clinical Trial To Evaluate Talimogene Laherparepvec In Combination With KEYTRUDA For Advanced Melanoma

News

Amgen has announced it will initiate a clinical trial of talimogene laherparepvec, an investigational immunotherapy, in combination with Merck’s KEYTRUDA (pembrolizumab), in patients diagnosed with regionally or distantly metastatic melanoma. ... Read more

December 9, 2014December 9, 2014

Study Reviews The Use Of Melanoma Chemopreventive Agents

News

Even though there have been significant advances in drug discovery and molecular research to identify drug targets, the incidence and mortality rates associated with melanoma have been continuously rising. Commonly ... Read more

December 8, 2014December 8, 2014

Array Signed Agreement To Regain Worldwide Rights To Binimetinib

News

Array BioPharma Inc. has announced it reached a conclusive agreement with Novartis allowing it to recover complete worldwide rights to binimetinib, a MEK inhibitor currently being investigated in three Phase ... Read more

December 5, 2014December 5, 2014

Study Finds Proteomic Biomarkers in Metastatic Melanoma

News

In a recent study titled “Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation”, published in the PlosOne journal, a team of researchers led by Dr. Vito ... Read more

December 4, 2014

Study Finds Combined PV-10 And Immune Checkpoint Inhibitors Efficient In Melanoma Treatment

News

During the 29th annual meeting of the Society for Immunotherapy of Cancer, Dr. Shari Pilon-Thomas of the Moffitt Cancer Center, presented a study titled “Efficacy of Intralesional Injection with PV-10 ... Read more

December 3, 2014December 3, 2014

Study Finds TERT Mutations Could Predict Survival Outcome in Melanoma Patients

News

In a recent study titled “TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma”, published in the Journal of the National Cancer Institute (JNCI), a group of researchers ... Read more

December 2, 2014

Study Finds immunoSEQ Assay Could Be Used to Predict Pembrolizumab Response in Melanoma Patients

News

A recent study published in Nature, successfully demonstrated that Adaptive Biotechnologies’s immunoSEQ Assay could aid in the identification of patients suffering from metastatic melanoma who are more likely to respond ... Read more

December 1, 2014December 1, 2014

Study Investigates Potent Cancer Vaccine

News

Recent research developed by scientists at the Washington University School of Medicine in St. Louis, titled “Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens” and published in the prestigious Nature ... Read more

November 28, 2014November 28, 2014

Study Finds Mechanism Behind Melanoma Patients’ Response to Pembrolizumab

News

Recent work supported by the Stand Up To Cancer (SU2C) – Cancer Research Institute (CRI) – Immunology Translational Research Dream Team, was published ahead of print in the prestigious Nature ... Read more

November 26, 2014November 26, 2014

Study Finds Key Mutations in Melanoma Patients Responsive to Immunotherapy

Melanoma, News

Timothy Chan, MD, PhD, and oncology fellow Alexandra Snyder Charen, MD, at the Memorial Sloan Kettering Cancer Center, are working to advance the way melanoma patients are treated with immunotherapy. The ... Read more

November 25, 2014November 25, 2014

Study Evaluated CT Tumor Size and Density as Predictors of Response And Outcome in Advanced Melanoma

News

In a recent study titled “Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome”, published in the Journal ... Read more

November 24, 2014November 24, 2014

Study Finds IL28B Polymorphism In Melanoma Patients Is Not A Predictor For Interferon Alpha Treatment

News

In a recent study titled “IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with Melanoma”, published in PlosOne, a team of researchers led by Dr. Katharina Grabmeier-Pfistershammer, ... Read more